Council for Innovation Promotion

🚨 Today, C4IP announced the appointment of two distinguished public servants and longtime intellectual property advocates to its Board: Governor Gary Locke and Congressman Lamar Smith. Gary Locke is the former Governor of Washington, U.S. Secretary of Commerce, and U.S.…

🛒 The Senate passed a resolution recognizing July as National Anti-Counterfeiting Month, highlighting growing bipartisan concern over the negative impacts of counterfeits. It's a timely reminder of the need for legislation like the SHOP SAFE Act. Learn more about SHOP SAFE:…

Don't miss this interview with C4IP Co-Chair and fmr. @USPTO Dir. David Kappos 🎙️ He discusses C4IP's 2025 Congressional Innovation Scorecard, the importance of passing pro-innovation legislation like PERA and the PREVAIL Act, how the patent system can promote AI innovation, and…

Check out our latest blog, where we fact-check claims about standard-essential patents and innovation! We argue that America needs stronger SEP rights — not weaker ones — to keep our domestic industry and innovation ecosystem strong. Read it here: c4ip.org/fact-check-set…

DYK? Patents play a critical role in startup success. According to a study, between 2011 and 2020, patent-holding startups secured deals that were 40% to 60% larger than those of non-patent-holding companies. Learn more: c4ip.org/new-op-ed-from…

📢 On Aug. 13 at 12 PM ET, join @FedSoc for a webinar on the Patent Eligibility Restoration Act. The event will feature remarks from C4IP's Jamie Simpson and Judge Kathleen O'Malley, alongside other industry experts. Register: fedsoc.org/events/the-pat…

📓 DYK? C4IP has a grant program for IP-related research, scholarship, and writings. We will provide grants of up to $25k to support original, empirically grounded research projects resulting in final written work products. For more details: c4ip.org/grant-program/

IP-intensive industries are essential to the U.S. economy 📈 The @USPTO found that IP-intensive industries make up over 40% of the U.S. economy and support around 63 million jobs. Learn more about the vital role that IP plays in driving U.S. economic growth:…

📜 Why does C4IP support the bipartisan NO FAKES Act? The bill would protect individuals from the unauthorized, AI-generated use of their voice, image, and likeness -- ensuring creators and individuals are protected from exploitation and fairly compensated for their work. Read…

So-called "patent evergreening," the alleged practice of filing additional patents on existing products to "extend" the original patent, is a myth. Follow-on patents don't extend earlier patents or block generics, and the @USPTO only grants patents on novel, useful, and…

By strengthening public-private collaboration, the @BayhDole Act ensured that federally funded research could be effectively commercialized and turned into impactful real-world products. In fact, the Bayh-Dole Act has resulted in approx. 3 new startups and 2 new products…

It was great to hear from such a well-versed panel of experts and keynote speaker @RepDeborahRoss at @ITIFdc's event today! Watch the full discussion here: buff.ly/QnuAQAm

Filing multiple patents for a single product isn't insidious. It's how innovation works. There are often many distinct and novel innovations that go into a single product, each of which requires its own patent. Don't let misinformation weaken U.S. innovation.

Why does C4IP oppose the Affordable Prescriptions for Patients Act? 🔍 The bill would arbitrarily limit the enforceability of certain patents -- not due to any alleged defect with the patents themselves, but simply due to the quantity of other patents owned by a litigant and the…

❌ Myth: Weakening protections for follow-on patents would benefit patients. ✅ Fact: Nine in 10 U.S. prescriptions are already filled with generics. Weakening follow-on patents would only chill the development of safer, more convenient, or more effective alternatives. Learn…